Primate models for cardiovascular drug research and development

Current Opinion in Investigational Drugs

Volumn 11, Issue 9, 2010, Pages 1025-1029

  Shen, You Tang ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Heart failure; hemodynamic; left ventricular function; myocardial ischemia; rapid ventricular pacing; regional blood flow

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CI 992; MICROSPHERE; R PEP 27; RENIN INHIBITOR; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CERCOPITHECIDAE; CONGESTIVE HEART FAILURE; DISEASE COURSE; DISEASE MODEL; DRUG RECEPTOR BINDING; DRUG RESEARCH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE PACING; HEART VENTRICLE REMODELING; HYPERTENSION; MACACA; MOLECULAR MECHANICS; MONKEY; NONHUMAN; PRIMATE; REVIEW;

ANIMALS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; HAPLORHINI; HEART FAILURE; MACACA FASCICULARIS; MODELS, ANIMAL; PRIMATES;

EID: 77956235290     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Colbert MC, Hall DG, Kimball TR, Witt SA, Lorenz JN, Kirby ML, Hewett TE, Klevitsky R, Robbins J: Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest (1997) 100(8): 1958-1968.
2. Huen DS, Fox A, Kumar P, Searle PF: Dilated heart failure in transgenic mice expressing the Epstein-Barr virus nuclear antigen-leader protein. J Gen Virol (1993) 74(Pt 7):1381-1391.
3. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK, Wight DC, Wagner TE, Ishikawa Y, Homcy CJ, Vatner SF: Adverse effects of chronic endogenous sympathetic drive induced by cardiac GSá overexpression. Circ Res (1996) 78(4): 517-524.
4. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-á. Circ Res (1997) 81(4):627-635.
5. Ellis PR Jr, Bailas NJ, Viskos JD, Wong SH, Hyland JW: Experimental heart failure in dogs. Arch Surg (1964) 89:299-306.
6. Nuttall A, Smith HJ, Loveday BE: A clinically relevant model of heart failure: Effects of ticlopidine. Cardiovasc Res (1985) 19(4):187-192.
7. Pfeffer JM, Pfeffer MA:Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure. Am J Med (1988) 84(3A):37-44.
8. Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, Jafri S, Hawkins ET, Goldstein S: A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol (1991) 260(4 Pt 2): H1379-H1384.
9. Armstrong PW, Stopps TP, Ford SE, de Bold AJ: Rapid ventricular pacing in the dog: Pathophysiologic studies of heart failure. Circulation (1986) 74(5):1075-1084.
10. Chow E, Woodard JC, Farrar DJ: Rapid ventricular pacing in pigs: An experimental model of congestive heart failure. Am J Physiol (1990) 258(5 Pt 2):H1603-H1605.
11. Hendrick DA, Smith AC, Kratz JM, Crawford FA, Spinale FG: The pig as a model of tachycardia and dilated cardiomyopathy. Lab Anim Sci (1990) 40(5):495-501.
12. Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N: Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects. Circulation (1987) 75(4):857-867.
13. Smith AH, Wolfgang EA, Flynn DM, Doe CP, Knight DR: Tachycardia-induced primate model of heart failure in cardiovascular drug discovery. J Pharmacol Toxicol Methods (2000) 43(2):125-131.
14. Shen YT, Yan L, Peppas A, Rossi F, Vatner DE, Sadoshima J, Vatner SF, Depre C: Activation of a cell survival program during post-ischemic heart failure in monkeys. Circulation (2005) 111(13):1721-1724.
15. Shen YT, Lin Y, Depre C, Resuello RRG, Natividad F, Peppas A, Rossi F, Takao N, Vatner DE, Vatner SF: A novel non-human primate model of myocardial infarction, left ventricular hypertrophy and congestive heart failure. FASEB J (2005) 19(4):Abs 243.
16. Larosa G, Armstrong PW, Seeman P, Forster C: â Adrenoceptor recovery after heart failure in the dog. Cardiovasc Res (1993) 27(3):489-493.
17. Moe GW, Stopps TP, Howard RJ, Armstrong PW: Early recovery from heart failure: Insights into the pathogenesis of experimental chronic pacing-induced heart failure. J Lab Clin Med (1988) 112(4):426-432.
18. Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman RE, Gallagher JJ, German LD: Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction. Am J Cardiol (1986) 57(8):563-570.
19. Shen YT, Lynch JJ, Shannon RP, Wiedmann RT: A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs. Am J Physiol (1999) 277(1 Pt 2):H388-H398.
20. Shen YT, Rossi F, Vatner SF: Nonhuman primate models for cardiovascular research. In: Cardiovascular Toxicology, Fourth Edition. Daniel Acosta Jr (Ed), Informa Healthcare, New York, NY, USA (2008):133-152.
21. Shen YT, Fallon JT, Iwase M, Vatner SF: Innate protection of baboon myocardium: Effects of coronary artery occlusion and reperfusion. Am J Physiol (1996) 270(5 Pt 2):H1812-H1818.
22. Shen YT, Vatner SF: Differences in myocardial stunning following coronary artery occlusion in conscious dogs, pigs, and baboons. Am J Physiol (1996) 270(4 Pt 2):H1312-H1322.
23. Asai K, Kudej RK, Shen YT, Yang GP, Takagi G, Kudej AB, Geng YJ, Sato N, Nazareno JB, Vatner DE, Natividad F et al: Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol (2000) 20(6):1493-1499.
24. Shannon RP, Mathier MA, Shen YT: Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs. J Am Coll Cardiol (2000) 35(5):1347-1354.
25. Qiu H, Depre C, Ghosh K, Resuello RG, Natividad FF, Rossi F, Peppas A, Shen YT, Vatner DE, Vatner SF: Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates. Circulation (2007) 116(6):669-676.
26. Park M, Shen YT, Gaussin V, Heyndrickx GR, Bartunek J, Resuello RR, Natividad FF, Kitsis RN, Vatner DE, Vatner SF: Apoptosis predominates in nonmyocytes in heart failure. Am J Physiol Heart Circ Physiol (2009) 297(2):H785-H791.
27. Arch JRS, Kaufmann AJ: â3 and atypical â-adrenoceptors. Med Res Rev (1993) 13(6):663-729.
28. Takahashi H, Yoshida T, Nishimura M, Nakanishi T, Kondo M, Yoshimura M: âadrenergic agonist, BRL-26830A, and á/â blocker, arotinolol, markedly increase regional blood flow in the brown adipose tissue in anesthetized rats. Jpn Circ J (1992) 56(9):936-942
29. Shen YT, Zhang H, Vatner SF: Peripheral vascular effects of â3 adrenergic receptor stimulation in conscious dogs. J Pharmacol Exp Ther (1994) 268(1):466-473.
30. Shen YT, Cervoni P, Claus T, Vatner SF: Differences in âadrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. J Pharmacol Exp Ther (1996) 278(3): 1435-1443.
31. Mernagh JR, Spiers EW, Adiseshiah M: The measurement of radioactive microspheres in biological samples. Phys Med Biol (1976) 21(4):646-650.
32. Prinzen FW, Bassingthwaighte JB: Blood flow distributions by microsphere deposition methods. Cariovasc Res (2000) 45(1):13-21.
33. Hale SL, Alker KJ, Kloner RA: Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation (1988) 78(2):428-434.
34. Glenny RW, Bernard S, Brinkley M: Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol (1993) 74(5):2585-2597.
35. Prinzen FW, Glenny RW: Developments in non-radioactive microsphere techniques for blood flow measurement. Cardiovasc Res (1994) 28(10):1467-1475.
36. Hui KY, Knight DR, Nussberger J, Hartley LH, Vatner SF, Haber E: Effects of renin inhibition in the conscious primate Macaca fascicularis. Hypertension (1989) 14(5):480-487.
37. Ryan MJ, Hicks GW, Batley BL, Rapundalo ST, Patt WC, Taylor DG, Keiser JA: Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys. J Pharmacol Exp Ther (1994) 268(1):372-379.
38. Chiou WL, Buehler PW: Comparison of oral absorption and bioavailability of drugs between monkey and human. Pharm Res (2002) 19(6):868-874.
39. Holzgrefe HH, Cavero I, Gleason CR: Analysis of the nonclinical telemetered ECG: Impact of logging rate and RR bin width in the dog and cynomolgus monkey. J Pharmacol Toxicol Methods (2007) 56(1):34-42.
40. Seki Y, Muneyuki K, Kandori A, Tsukada K, Terao K, Ageyama N: Standardization of magnetocardiography in nonhuman primates. Phys Med Biol (2008) 53(6):1609-1618.
41. Lynch JJ 3rd, Wilson AW, Hernandez LE, Nelson RA, Marsh KC, Cox BF, Mittelstadt SW: Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys. Br J Pharmacol (2008) 154(7):1439-1445.
42. Ishizaka T, Yoshimatsu Y, Ozawa M, Kimotsuki T, Takasaki W, Manabe S, Yasuda M: Evaluation of drug-induced QT prolongation in a halothane-anesthetized monkey model: Effects of sotalol. J Pharmacol Toxicol Methods (2009) 59(2): 86-93.
43. Roth GS, Mattison JA, Ottinger MA, Chachich ME, Lane MA, Ingram DK: Aging in rhesus monkeys: Relevance to human health interventions. Science (2004) 305(5689):1423-1426.
44. Fujiyama A, Watanabe H, Toyoda A, Taylor TD, Itoh T, Tsai SF, Park HS, Yaspo ML, Lehrach H, Chen Z, Fu G et al: Construction and analysis of a human-chimpanzee comparative clone map. Science (2002) 295(5552):131-134.
45. Cáceres M, Lachuer J, Zapala MA, Redmond JC, Kudo L, Geschwind DH, Lockhart DJ, Preuss TM, Barlow C: Elevated gene expression levels distinguish human from non-human primate brains. Proc Natl Acad Sci USA (2003) 100(22): 13030-13035.
46. Marvanová M, Ménager J, Bezard E, Bontrop RE, Pradier L, Wong G: Microarray analysis of nonhuman primates: Validation of experimental models in neurological disorders. FASEB J (2003) 17(8):929-931.
47. Khaitovich P, Muetzel B, She X, Lachmann M, Hellmann I, Dietzsch J, Steigele S, Do HH, Weiss G, Enard W, Heissig F et al: Regional patterns of gene expression in human and chimpanzee brains. Genome Res (2004) 14(8):1462-1473.
48. Dillman JF 3rd, Phillips CS: Comparison of non-human primate and human whole blood tissue gene expression profiles. Toxicol Sci (2005) 87(1):306-314.